Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils

Pain

Volumn 67, Issue 1, 1996, Pages 189-195

  Rupniak, Nadia M J ^a   Carlson, Emma ^a   Boyce, Susan ^a   Webb, Janine K ^a   Hill, Raymond G ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

CNS penetration; Formalin test; Gerbil; Pain; Tachykinin NK1 receptor

Indexed keywords

3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; 5 AMINOVALERYLSUBSTANCE P [7-11][9 PROLINE 10 (N METHYLLEUCINE)]; FORMALDEHYDE; TACHYKININ;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; ENANTIOMER; FEMALE; GERBIL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

EID: 0030246919     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)03109-0     Document Type: Article

References (32)

1. 1 receptors by use of the non-peptide antagonist, CP-96,345. Br. J. Pharmacol. 104:1991;292-293.
2. 1 receptor antagonist, (±)-CP-96,345, produces antinociceptive and anti-oedema effects in the rat. Br. J. Pharmacol. 105:1992;508-510.
3. 1 receptor antagonist, CP-99,994, in ferrets. Eur. J. Pharmacol. 249:1993;R3.
4. 1 receptor antagonists: comparison of behavioural and electrophysiological tests, I.A.S.P. Publications Congress Abstracts, 1993, p. 231.
5. 1 receptor activation in gerbils. Eur. J. Pharmacol. 254:1994;245-249.
6. Caeser M., Seabrook G.R., Kemp J.A. Block of voltage-dependent sodium currents by the substance P receptor antagonist (±)-CP-96,345 in neurones cultured from rat cortex. Br. J. Pharmacol. 109:1993;918-924.
7. 1 antagonist, on nociceptive transmission in the rat spinal cord. Neurosci. Lett. 157:1993;149-152.
8. de Koninck Y., Henry J.L. Substance P-mediated slow excitatory potential elicited in dorsal horn neurones in vivo by noxious stimulation. Proc. Natl. Acad. Sci. USA. 88:1991;11344-11348.
9. Graham E.A., Turpin M.P., Stubbs C.M. Characterisation of the tachykinin-induced hindlimb thumping response in gerbils. Neuropeptides. 4:1993;228.
10. Hagan R.M., Ireland S.J., Jordan C.C., Beresford I.J.M., Deal M.J., Ward P. Receptor-selective peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function. Neuropeptides. 19:1991;127-135.
11. 1 antagonists 1: determination of the relative and absolute stereochemical requirements. Bioorg. Med. Chem. Lett. 4:1994;2545-2550.
12. 1 antagonists 2: investigation of the effect of N-substitution. Bioorg. Med. Chem. Lett. 5:1995;205-212.
13. 1 receptor antagonist, has local anaesthetic-like effects in a mammalian sciatic nerve preparation. Regul. Pept. 52:1994;39-46.
14. 1 receptor antagonist, on facilitation of a nociceptive spinal reflex in the rat. Br. J. Pharmacol. 109:1993;713-718.
15. Longmore J., Swain C.J., Hill R.G. Neurokinin receptors. Drug News Perspect. 8:1995;5-23.
16. Malmberg A.B., Yaksh T.L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 257:1992;1276-1278.
17. McCarson K.E., Goldstein B.D. Timecourse of the alteration in substance P levels in the dorsal horn following formalin: blockade by naloxone. Pain. 41:1990;95-100.
18. 1 receptor. J. Pharmacol. Exp. Ther. 267:1993;472-479.
19. Nagahisa A., Asai R., Kanai Y., Murase A., Tsuchiya-Nakagaki M., Nakagaki T., Shieh T.-C., Taniguchi K. Non-specific activity of (±)-CP-96,345 in models of pain and inflammation. Br. J. Pharmacol. 107:1992;273-275.
20. Radhakrishnan V., Henry J.L. The novel substance P antagonist, CP-96,345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P. Neurosci. Lett. 132:1991;39-43.
21. 1 receptor antagonists: non-specific effects of racemic RP67580. Br. J. Pharmacol. 110:1993;1607-1613.
22. 1 receptor antagonist CP-99,994 in conscious gerbils. Br. J. Pharmacol. 116:1995;1937-1943.
23. 1 receptor antagonists. Eur. J. Pharmacol. 265:1994;179-183.
24. 2+ channels. Eur. J. Pharmacol. 219:1992;491-492.
25. 1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology. 34:1995;255-261.
26. 1 receptor antagonist CP-99,994 in antinociceptive tests in rat, mouse and gerbil. Eur. J. Pharmacol. 271:1994;481-487.
27. 1 receptor antagonist CP-99,994 attenuates cisplatin-induced emesis in the ferret. Eur. J. Pharmacol. 250:1993;R5.
28. 1 receptor antagonist: behavioural effects. Neuropeptides. 26:1994;38.
29. 1 selective antagonist, CP-96,345: antinociception in the absence of motor disfunction. Life Sci. 49:1991;1955-1963.
30. Yashpal K., Radhakrishnan V., Coderre T.J., Henry J.L. CP-96,345, but not its stereoisomer, CP-96,344, blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience. 52:1993;1039-1047.
31. Xu X.-Y., Dalsgaard C.J., Wiesenfeld-Hallin Z. Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fibre-conditioning stimulation. Eur. J. Pharmacol. 216:1992;337-344.
32. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.